Clayton Industries has gathered the following information about the actual sales revenues and expenses for its pharmaceuticals segment for the most recent year. B (Click the icon to view the actual data.) Budgeted data for the same time period for the pharmaceutical segment are as follows (all data are in millions): (Click the icon to view the budgeted data.) Prepare a segment margin performance report for the pharmaceutical segment. Calculate a variance and a variance percentage for each line in the report. Round to the nearest hundredth for the variance percentages (for example, if your answer is 16.2384%, round it to 16.24%). Begin by preparing the performance report through the contribution margin line. Next, complete the report through the segment margin line, and then, finally, complete the report through the operating income line. (Enter the variances as positive numbers. Round the variance percentages to the nearest hundredth percent, X.XX%.) Performance Report Clayton - Pharmaceutical Segment . For Fiscal Year Ending December 31 Actual Bugeted Variance Variance % Sales % Less Variable Expenses: Variable Cost of Goods Sold % Variable Operating Expenses % Contribution Margin % Sales $ 1,360,800 $ 257,400 $ 180, 180 Variable Cost of Goods Sold Variable Operating Expenses Direct Fixed Manufacturing Overhead Direct Fixed Operating Expenses Common Fixed Expenses $ $ 110,210 $ 21,840 $ 20,600 Budgeted sales in units 9,000 140 26 $ 22 Budgeted average selling price per unit Variable Cost of Goods Sold per unit Variable Operating Expenses per unit Direct Fixed Manufacturing Overhead (in total) Direct Fixed Operating Expenses (in total) Common Fixed Expenses Allocated to the Pharmaceutical Segment $ 103,000 21,000 20,000